Cargando…

Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia

Currently available pharmacological treatment of post-ischemia-reperfusion brain injury has limited effectiveness. This review provides an assessment of the current state of neurodegeneration treatment due to ischemia-reperfusion brain injury and focuses on the role of curcumin in the diet. The purp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ułamek-Kozioł, Marzena, Czuczwar, Stanisław J., Januszewski, Sławomir, Pluta, Ryszard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014172/
https://www.ncbi.nlm.nih.gov/pubmed/31947633
http://dx.doi.org/10.3390/ijms21020517
_version_ 1783496568380325888
author Ułamek-Kozioł, Marzena
Czuczwar, Stanisław J.
Januszewski, Sławomir
Pluta, Ryszard
author_facet Ułamek-Kozioł, Marzena
Czuczwar, Stanisław J.
Januszewski, Sławomir
Pluta, Ryszard
author_sort Ułamek-Kozioł, Marzena
collection PubMed
description Currently available pharmacological treatment of post-ischemia-reperfusion brain injury has limited effectiveness. This review provides an assessment of the current state of neurodegeneration treatment due to ischemia-reperfusion brain injury and focuses on the role of curcumin in the diet. The purpose of this review was to provide a comprehensive overview of what was published about the benefits of curcumin influence on post-ischemic brain damage. Some data on the clinical benefits of curcumin treatment of post-ischemic brain in terms of clinical symptoms and adverse reactions have been reviewed. The data in this review contributes to a better understanding of the potential benefits of curcumin in the treatment of neurodegenerative changes after ischemia and informs scientists, clinicians, and patients, as well as their families and caregivers about the possibilities of such treatment. Due to the pleotropic properties of curcumin, including anti-amyloid, anti-tau protein hyperphosphorylation, anti-inflammatory, anti-apoptotic, and neuroprotective action, as well as increasing neuronal lifespan and promoting neurogenesis, curcumin is a promising candidate for the treatment of post-ischemic neurodegeneration with misfolded proteins accumulation. In this way, it may gain interest as a potential therapy to prevent the development of neurodegenerative changes after cerebral ischemia. In addition, it is a safe substance and inexpensive, easily accessible, and can effectively penetrate the blood–brain barrier and neuronal membranes. In conclusion, the evidence available in a review of the literature on the therapeutic potential of curcumin provides helpful insight into the potential clinical utility of curcumin in the treatment of neurological neurodegenerative diseases with misfolded proteins. Therefore, curcumin may be a promising supplementary agent against development of neurodegeneration after brain ischemia in the future. Indeed, there is a rational scientific basis for the use of curcumin for the prophylaxis and treatment of post-ischemic neurodegeneration.
format Online
Article
Text
id pubmed-7014172
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70141722020-03-09 Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia Ułamek-Kozioł, Marzena Czuczwar, Stanisław J. Januszewski, Sławomir Pluta, Ryszard Int J Mol Sci Review Currently available pharmacological treatment of post-ischemia-reperfusion brain injury has limited effectiveness. This review provides an assessment of the current state of neurodegeneration treatment due to ischemia-reperfusion brain injury and focuses on the role of curcumin in the diet. The purpose of this review was to provide a comprehensive overview of what was published about the benefits of curcumin influence on post-ischemic brain damage. Some data on the clinical benefits of curcumin treatment of post-ischemic brain in terms of clinical symptoms and adverse reactions have been reviewed. The data in this review contributes to a better understanding of the potential benefits of curcumin in the treatment of neurodegenerative changes after ischemia and informs scientists, clinicians, and patients, as well as their families and caregivers about the possibilities of such treatment. Due to the pleotropic properties of curcumin, including anti-amyloid, anti-tau protein hyperphosphorylation, anti-inflammatory, anti-apoptotic, and neuroprotective action, as well as increasing neuronal lifespan and promoting neurogenesis, curcumin is a promising candidate for the treatment of post-ischemic neurodegeneration with misfolded proteins accumulation. In this way, it may gain interest as a potential therapy to prevent the development of neurodegenerative changes after cerebral ischemia. In addition, it is a safe substance and inexpensive, easily accessible, and can effectively penetrate the blood–brain barrier and neuronal membranes. In conclusion, the evidence available in a review of the literature on the therapeutic potential of curcumin provides helpful insight into the potential clinical utility of curcumin in the treatment of neurological neurodegenerative diseases with misfolded proteins. Therefore, curcumin may be a promising supplementary agent against development of neurodegeneration after brain ischemia in the future. Indeed, there is a rational scientific basis for the use of curcumin for the prophylaxis and treatment of post-ischemic neurodegeneration. MDPI 2020-01-14 /pmc/articles/PMC7014172/ /pubmed/31947633 http://dx.doi.org/10.3390/ijms21020517 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ułamek-Kozioł, Marzena
Czuczwar, Stanisław J.
Januszewski, Sławomir
Pluta, Ryszard
Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
title Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
title_full Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
title_fullStr Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
title_full_unstemmed Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
title_short Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
title_sort substantiation for the use of curcumin during the development of neurodegeneration after brain ischemia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014172/
https://www.ncbi.nlm.nih.gov/pubmed/31947633
http://dx.doi.org/10.3390/ijms21020517
work_keys_str_mv AT ułamekkoziołmarzena substantiationfortheuseofcurcuminduringthedevelopmentofneurodegenerationafterbrainischemia
AT czuczwarstanisławj substantiationfortheuseofcurcuminduringthedevelopmentofneurodegenerationafterbrainischemia
AT januszewskisławomir substantiationfortheuseofcurcuminduringthedevelopmentofneurodegenerationafterbrainischemia
AT plutaryszard substantiationfortheuseofcurcuminduringthedevelopmentofneurodegenerationafterbrainischemia